Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension

scientific article published on 21 November 2005

Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AMJCARD.2005.08.028
P698PubMed publication ID16442372

P2093author name stringMatthias Pfisterer
David Conen
Andreas Zeller
Benedict Martina
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectleft ventricular hypertrophyQ1628627
P304page(s)249-252
P577publication date2005-11-21
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleUsefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension
P478volume97

Reverse relations

cites work (P2860)
Q37605906An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol
Q37171767Antemortem Screening for Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta).
Q39813021Association of increased arterial stiffness and inflammation with proteinuria and left ventricular hypertrophy in non-diabetic hypertensive patients
Q35625858Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA)
Q37336291C-reactive Protein among Community-Dwelling Hypertensives on Single-agent Antihypertensive Treatment
Q83368019C-reactive protein and echocardiography have little impact on risk stratification in never-treated hypertensive patients
Q38162367C-reactive protein and hypertension
Q40617829Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population
Q33762816Impaired flow-mediated vasodilatation is associated with increased left ventricular mass in a multiethnic population. The Northern Manhattan Study
Q36754237Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions
Q48455645N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea
Q37008579NT-proBNP and the diagnosis of left ventricular systolic dysfunction within two acute NHS trust catchment areas: the initial Teesside experience
Q33902623Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
Q34808068Nocturnal Blood Pressure Pattern Affects Left Ventricular Remodeling and Late Gadolinium Enhancement in Patients with Hypertension and Left Ventricular Hypertrophy
Q38930342Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction
Q48187642Plasma N terminal pro-brain natriuretic peptide levels and its determinants in a multi-ethnic population
Q37355268Relations of biomarkers representing distinct biological pathways to left ventricular geometry
Q46193259Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults
Q80472810Serum markers of systemic right ventricular function and exercise performance
Q43270430Uric acid is an independent predictor of arterial stiffness in hypertensive patients

Search more.